spacer
home > ict > winter 2008 > we can be heroes
PUBLICATIONS
International Clinical Trials

We Can be Heroes

Describing the public health benefits of promoting patient participation, Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) challenge public perceptions of clinical trials

A GLOBAL PROBLEM

Clinical research is essential for developing treatments that improve public health. Without it, many medical advances that ease human suffering, offer better treatment options and even cure life-threatening illnesses would never have been introduced.

Despite the high importance of clinical research and the access to investigational new treatments that it affords, patient participation rates are low. As few as 10 per cent of eligible patients in the US participate in clinical trials (1) – a figure that is only slightly higher than other parts of the world, which sit at an overall participation rate of only six to eight per cent of eligible patients (2). Pharmaceutical companies are increasingly investing in communication programmes to ensure awareness and knowledge of the studies that they are conducting and, ultimately, to increase patient participation in clinical trials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Kenneth A Getz is the chairman of CISCRP – a non-profit organisation that he founded to educate and raise public awareness of the clinical research enterprise – and a Senior Research fellow at the Tufts Center for the Study of Drug Development, where he studies R&D management and operating models, investigative sites, outsourcing and study volunteer trends and policies. A wellknown speaker, Ken has published over 150 articles and two books, and serves on a number of corporate and non-profit boards. Ken is also the founder and former CEO of CenterWatch, a leading publisher in the clinical trials industry.

Jim Kremidas leads the clinical trial patient recruitment and retention efforts at Eli Lilly and Company. His role focuses on predicting and accelerating the enrolment rates for all corporate studies. Jim is a member of the Steering Committee for the Center for Information and Study on Clinical Research Participation (CISCRP).

Elizabeth Carfioli has over 10 years of experience in the strategic planning and implementation of global patient recruitment and retention programmes, having worked for both agencies and sponsors. She is currently working for Ogilvy Healthworld Consulting, providing strategic counsel to clients on improving internal processes for enrolment acceleration.

Rachael Butlin is an Account Manager at Fast4wD Ogilvy, a specialised global patient recruitment and retention company. She has a business and marketing background, and has combined this experience with her knowledge of study stakeholder needs in outlining bespoke global programmes for a number of top pharmaceutical study sponsors. Her expertise spans numerous therapy areas including pain, oncology and mental health.

spacer
Kenneth A Getz
spacer
spacer
spacer
Jim Kremidas
spacer
spacer
spacer
Elizabeth Carfioli
spacer
spacer
spacer
Rachael Butlin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Stripping the confusion out of PVC curtains... and a new seat range.

Teknomek Ltd

With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement